Foghorn Therapeutics Inc.
FHTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$86,620 | -$98,426 | -$108,882 | -$101,320 |
| Dep. & Amort. | $3,120 | $3,451 | $7,901 | $3,227 |
| Deferred Tax | $0 | $0 | $0 | $1,412 |
| Stock-Based Comp. | $11,893 | $16,186 | $0 | $8,384 |
| Change in WC | -$32,266 | -$41,879 | $281,546 | $33,441 |
| Other Non-Cash | $3,467 | $2,562 | $13,047 | $4,606 |
| Operating Cash Flow | -$100,406 | -$118,106 | $193,612 | -$50,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$906 | -$1,224 | -$1,210 | -$3,313 |
| Net Acquisitions | $0 | $0 | $0 | -$39,486 |
| Inv. Purchases | -$261,470 | -$73,901 | -$409,345 | -$99,984 |
| Inv. Sales/Matur. | $232,472 | $219,575 | $166,233 | $139,470 |
| Other Inv. Act. | $0 | $0 | $0 | $39,486 |
| Investing Cash Flow | -$29,904 | $144,450 | -$244,322 | $36,173 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$21,205 |
| Stock Issued | $103,401 | $0 | $1,763 | $42,205 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,027 | $1,778 | $0 | $1,418 |
| Financing Cash Flow | $105,428 | $1,778 | $1,763 | $22,418 |
| Forex Effect | $0 | $0 | $25 | $0 |
| Net Chg. in Cash | -$24,882 | $28,122 | -$48,922 | $8,341 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82,044 | $53,922 | $101,136 | $94,528 |
| End Cash | $57,162 | $82,044 | $52,214 | $102,869 |
| Free Cash Flow | -$101,312 | -$119,330 | $192,402 | -$53,563 |